18F-grazy-02 PET/CT of Granzyme B Expression for Monitoring Immunotherapy
NCT07724535
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
RECRUITING
Status
30
Enrollment
OTHER
Sponsor class
Conditions
Cancer
Interventions
DRUG:
18F-grazy-02
Sponsor
Peking University Cancer Hospital & Institute